How a new drug interacts with other medications in healthy adults
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This early-phase study tests how a new medicine (Y-4) moves through the body when taken with two other drugs (pregabalin and riluzole) in healthy people. It helps doctors understand the safety and dosing before testing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 18 to 45 years.
- Your weight must be at least 110 lbs (50 kg) for men or 99 lbs (45 kg) for women, with a body mass index (BMI) between 19 and 28.
- You must not have significant allergies to any of the study drugs or ingredients.
- You must not be taking certain medications, including antidepressants, sedatives, or opioids, within 2 months before the study.
- You must not have a history of mental health conditions, dizziness, or sleep apnea.
- You must agree to avoid smoking, alcohol, and caffeine during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a new tablet called Y-4 interacts with pregabalin and riluzole in healthy people. It helps doctors understand how these drugs work together in the body.
This study tests how food affects the way a new medicine (Y-4 tablet) is processed in the body. It is looking for healthy volunteers to take a single dose of the study drug and have their blood levels checked over time.
This trial tests the safety and how the body processes a new medicine called Y-4. Healthy adults ages 18 to 45 can join to help researchers understand how the drug works and if it has any side effects.
This study tests a new medicine called Y-3 in people with mild or moderate liver problems and in healthy volunteers. It aims to see how the body handles the drug, so doctors can learn the right dose for people with liver issues.
This trial tests a new drug called Y-4 for people with lingering nerve pain after shingles (postherpetic neuralgia). If you have had pain for more than a month after your rash healed, this study may help find a new treatment option.
This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
Hear when a new Healthy Male and Female Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.